Tezacaftor, Ivacaftor Combination Generally Safe, Well Tolerated in Children With CF Under Age 12
Different CFTR Potentiators Bind to Same Flexible Spot on Protein, Study Finds


Eluforsen Improves CFTR Function in Cellular and Animal Models of CF, Study Says


Kalydeco’s Safety and Benefits Studied in CF Patients with Severe Lung Disease


Specific Variables Improve Disease Severity Discrimination Among CF Transplant Candidates


Babies Treated with Synagis Show No Lasting Benefits in Lung Health as 7-Year-Olds, Real-world Study


Organoids grown in microfluidic device may help cf patients with diabetes


Modified and More Rigorous Cleansing Procedure May Better Prepare CF Patients for Colonoscopy, Study


Combining Antibiotics, Researchers Deliver One-Two Punch Against P. aeruginosa
AiCuris and Lysando Join Forces in the Fight Against Antimicrobial Resistance